"
Team:NJU China/Project/T cell
From 2013.igem.org
(Difference between revisions)
| Line 412: | Line 412: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Project">Project</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Project</a> | ||
<ul> | <ul> | ||
| - | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Overview</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Chassis</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Targeting Module</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Killing Module</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Achievement</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 424: | Line 424: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Human Practice</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Human Practice</a> | ||
<ul> | <ul> | ||
| - | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Free debate</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Reach the unreached</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Workshop</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Collaboration</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 433: | Line 433: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Wet lab">Wet lab</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Wet lab">Wet lab</a> | ||
<ul> | <ul> | ||
| - | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Protocol">Protocol</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Notebook">Lab notes</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Data Page">Data Page</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Parts">Parts</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 442: | Line 442: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Safety">Safety</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Safety">Safety</a> | ||
<ul> | <ul> | ||
| - | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Safety">Safety form</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Virus-related_safety">Virus-related safety</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 451: | Line 451: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Extras">Extras</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Extras">Extras</a> | ||
<ul> | <ul> | ||
| - | <li><a href=" | + | <li><a href="https://igem.org/2013_Judging_Form?id=1180">Judging criteria</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Attributions">Attribution</a></li> |
| - | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Acknowledgement">Acknowledgement</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Revision as of 09:02, 28 October 2013
<!DOCTYPE html>
T cell: T cell is the target of HIV infection, so we were thinking about whether we can use a short peptide from the HIV envelope protein to direct our exosomes to the T cells. Therefore we cloned the GP 120(a peptide from HIV envelope protein) to the lamp 2b and we use pcDNA 3.1(+) as our vector.
